Trials / Terminated
TerminatedNCT03578952
Evaluation of Effectiveness and Safety of Evolut R Valve In Patients With Pure Aortic Regurgitation
Evaluation of Effectiveness and Safety of Evolut R Valve In Patients With Pure Aortic Regurgitation Transcatheter Aortic Valve Replacement for Pure Severe Aortic Regurgitation Pilot Study
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the efficacy and safety of transcatheter aortic valve replacement (TAVR) in severe 'pure Aortic regurgitation (AR)' using Evolut R valve (Medtronic, Minneapolis, MN).
Conditions
- Aortic Valve
- Aortic Valve Insufficiency
- Aortic Regurgitation
- Regurgitation, Aortic Valve
- Aortic Incompetence
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TAVR with Evolut R valve | TAVR with Evolut R valve |
Timeline
- Start date
- 2018-08-10
- Primary completion
- 2019-02-21
- Completion
- 2019-02-21
- First posted
- 2018-07-06
- Last updated
- 2019-02-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03578952. Inclusion in this directory is not an endorsement.